Given the crucial role of CDK2 in centriole amplification and the high frequency of its deregulation in early stage breast cancer [12,29], we asked here whether targeting CDK2 can prevent centrosome aberrations in breast cancer cells. The gene discussed is CDK2; the disease is breast cancer.